In a mouse model of pancreatic ductal carcinoma (PDAC), FAK deletion in PDAC cells through CRISPR/Cas9 gene-editing reduced tumor growth and enhanced CD8+ T cell infiltration. The gene discussed is PTK2; the disease is neoplasm.